Docusign (NASDAQ:DOCU – Free Report) had its price target hoisted by BTIG Research from $75.00 to $90.00 in a research note issued to investors on Wednesday morning,Benzinga reports. BTIG Research currently has a buy rating on the stock.
A number of other research firms have also recently issued reports on DOCU. Citizens Jmp reiterated a “market outperform” rating and set a $86.00 target price on shares of Docusign in a report on Friday, September 4th. Evercore set a $65.00 price target on Docusign in a research note on Friday, September 4th. Piper Sandler boosted their price target on Docusign from $52.00 to $75.00 and gave the company a “neutral” rating in a report on Friday, September 4th. Robert W. Baird boosted their price target on Docusign from $55.00 to $72.00 and gave the company a “neutral” rating in a report on Friday, September 4th. Finally, Bank of America upped their price objective on Docusign from $58.00 to $64.00 and gave the stock an “underperform” rating in a research report on Friday, September 4th. Three investment analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Docusign has an average rating of “Hold” and an average target price of $69.50.
Check Out Our Latest Stock Analysis on DOCU
Docusign Stock Down 0.7%
Shares of NASDAQ DOCU opened at $74.56 on Wednesday. Docusign has a twelve month low of $40.16 and a twelve month high of $85.90. The stock has a market cap of $13.94 billion, a price-to-earnings ratio of 47.51, a P/E/G ratio of 2.94 and a beta of 0.80. The company’s fifty day moving average is $75.06 and its 200-day moving average is $56.40.
Docusign (NASDAQ:DOCU – Get Free Report) last released its quarterly earnings data on Thursday, September 3rd. The company reported $1.16 EPS for the quarter, beating analysts’ consensus estimates of $1.09 by $0.07. Docusign had a net margin of 9.82% and a return on equity of 18.29%. The business had revenue of $875.75 million during the quarter, compared to analysts’ expectations of $867.22 million. During the same quarter in the prior year, the company earned $0.30 EPS. The firm’s quarterly revenue was up 9.4% on a year-over-year basis. On average, research analysts anticipate that Docusign will post 2.15 EPS for the current fiscal year.
Insider Buying and Selling
In other news, Director Mary Wilderotter sold 1,000 shares of the business’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $68.80, for a total value of $68,800.00. Following the sale, the director owned 2,199 shares of the company’s stock, valued at $151,291.20. The trade was a 31.26% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Allan Thygesen sold 26,250 shares of the business’s stock in a transaction on Thursday, October 1st. The stock was sold at an average price of $69.29, for a total transaction of $1,818,862.50. Following the completion of the sale, the chief executive officer directly owned 166,801 shares in the company, valued at approximately $11,557,641.29. This represents a 13.60% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 154,168 shares of company stock valued at $10,491,896 over the last ninety days. Insiders own 0.59% of the company’s stock.
Institutional Investors Weigh In On Docusign
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Choreo LLC boosted its holdings in shares of Docusign by 1.8% during the third quarter. Choreo LLC now owns 7,430 shares of the company’s stock worth $499,000 after acquiring an additional 129 shares during the period. Private Advisor Group LLC grew its position in shares of Docusign by 0.9% in the third quarter. Private Advisor Group LLC now owns 14,885 shares of the company’s stock valued at $1,000,000 after purchasing an additional 135 shares during the last quarter. Bessemer Group Inc. increased its stake in shares of Docusign by 15.6% during the third quarter. Bessemer Group Inc. now owns 1,262 shares of the company’s stock worth $85,000 after purchasing an additional 170 shares during the period. Covestor Ltd increased its stake in shares of Docusign by 14.1% during the third quarter. Covestor Ltd now owns 1,693 shares of the company’s stock worth $113,000 after purchasing an additional 209 shares during the period. Finally, Pzena Investment Management LLC increased its stake in shares of Docusign by 4.7% during the third quarter. Pzena Investment Management LLC now owns 4,720 shares of the company’s stock worth $317,000 after purchasing an additional 210 shares during the period. 77.64% of the stock is owned by institutional investors.
Docusign Company Profile
DocuSign, Inc. provides software for preparing, signing, managing and automating agreements. Its platform helps businesses and individuals complete agreements digitally, reducing reliance on paper-based processes. The company’s offerings include DocuSign eSignature, which enables users to sign and request signatures electronically, as well as tools for contract lifecycle management and agreement workflows. Its Intelligent Agreement Management products use artificial intelligence to help organizations analyze and manage agreement-related information and processes.
Further Reading
- Five stocks we like better than Docusign
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
